Michael P Curry (Michael Curry, M P Curry)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Alcohol Use Disorder

Top Venues

Hepatology communications

Alimentary pharmacology & therapeutics

International journal of hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Zachary Fricker, Gordon Jiang, Het Patel, Annabel McLaughlin, Sofia Izunza Barba, Sebastian Niezen, Michael P Curry
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis. Hepatology communications 8 (1) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Michael P Curry, Edward Tam, Caitlin Schneider, Noha Abdelgelil, Tarek Hassanein, Nezam H Afdhal
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study. International journal of hepatology 2024 (2024)
Zachary Fricker, Gordon Jiang, Het Patel, Annabel McLaughlin, Sofia Izunza Barba, Sebastian Niezen, Michael P Curry
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis. Hepatology communications 8 (1) (2024)
Zachary Fricker, Gordon Jiang, Het Patel, Annabel McLaughlin, Sofia Izunza Barba, Sebastian Niezen, Michael P Curry
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis. Hepatology communications 8 (1) (2024)
Zachary Fricker, Gordon Jiang, Het Patel, Annabel McLaughlin, Sofia Izunza Barba, Sebastian Niezen, Michael P Curry
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis. Hepatology communications 8 (1) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Zachary Fricker, Gordon Jiang, Het Patel, Annabel McLaughlin, Sofia Izunza Barba, Sebastian Niezen, Michael P Curry
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis. Hepatology communications 8 (1) (2024)
Michael P Curry, Edward Tam, Caitlin Schneider, Noha Abdelgelil, Tarek Hassanein, Nezam H Afdhal
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study. International journal of hepatology 2024 (2024)
Ammar Sarwar, Muhammad Saad Malik, Nhi H Vo, Leo L Tsai, Muhammad M Tahir, Michael P Curry, Andreea M Catana, Andrea J Bullock, John A Parker, Devin E Eckhoff, Imad A Nasser, Jeffrey L Weinstein, Muneeb Ahmed
Efficacy and Safety of Radiation Segmentectomy with 90 Y Resin Microspheres for Hepatocellular Carcinoma. Radiology 311 (2) (2024)
Ammar Sarwar, Muhammad Saad Malik, Nhi H Vo, Leo L Tsai, Muhammad M Tahir, Michael P Curry, Andreea M Catana, Andrea J Bullock, John A Parker, Devin E Eckhoff, Imad A Nasser, Jeffrey L Weinstein, Muneeb Ahmed
Efficacy and Safety of Radiation Segmentectomy with 90 Y Resin Microspheres for Hepatocellular Carcinoma. Radiology 311 (2) (2024)
Zachary Fricker, Gordon Jiang, Het Patel, Annabel McLaughlin, Sofia Izunza Barba, Sebastian Niezen, Michael P Curry
A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis. Hepatology communications 8 (1) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Michael P Curry, Hugo E Vargas, Alex S Befeler, Nikolaos T Pyrsopoulos, Vilas R Patwardhan, Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatology communications 7 (1) (2023)
Michael P Curry, Hugo E Vargas, Alex S Befeler, Nikolaos T Pyrsopoulos, Vilas R Patwardhan, Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatology communications 7 (1) (2023)
Michael P Curry, Hugo E Vargas, Alex S Befeler, Nikolaos T Pyrsopoulos, Vilas R Patwardhan, Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatology communications 7 (1) (2023)
Michael P Curry, Hugo E Vargas, Alex S Befeler, Nikolaos T Pyrsopoulos, Vilas R Patwardhan, Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatology communications 7 (1) (2023)
Michael P Curry, Hugo E Vargas, Alex S Befeler, Nikolaos T Pyrsopoulos, Vilas R Patwardhan, Khurram Jamil
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatology communications 7 (1) (2023)
John C Messinger, Douglas W Hanto, Michael P Curry, Keren Ladin
Liver transplantation in alcohol-associated liver disease: ensuring equity through new processes. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2023)
Florence S H Wong, Stephen Chris Pappas, Rajender K Reddy, Hugo Vargas, Michael P Curry, Arun J Sanyal, Khurram Jamil
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Alimentary pharmacology & therapeutics 56 (8) (2022)
S L Flamm, B Bacon, Michael P Curry, S Milligan, C U Nwankwo, N Tsai, Zobair M Younossi, N Afdhal
Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network. Alimentary pharmacology & therapeutics 47 (11) (2018)
Michael P Curry, E B Tapper, B Bacon, D Dieterich, S L Flamm, L Guest, K V Kowdley, Y Lee, S Milligan, N Tsai, Zobair M Younossi, N H Afdhal
Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients. Alimentary pharmacology & therapeutics 46 (5) (2017)